Nurse navigators and APPs are key members of the multidisciplinary team who can lead and implement QI efforts to ensure ...

An oncology nurse discusses 4 common barriers certain patient populations face when it comes to oncology clinical trials, and ...

The FDA extended the Prescription Drug User Fee Act date for the biologics license application seeking approval of ...

The novel drug SHR-A1921 was safe and efficacious in patients with platinum-resistant ovarian cancer, according to phase 1 data.

An ad-hoc analysis found a higher rate of severe and life-threatening infections in patients with RET-mutant lung cancer ...

With newer breast cancer treatments, it’s essential that nurses and APPs educate themselves and advocate for their patients.

A nurse practitioner discusses how breast cancer treatment can impact sexual health, and how nurses and APPs can guide ...

FDA Approves Zolbetuximab Regimen for Locally Advanced, Unresectable Gastric/GEJ Adenocarcinoma ...

October 2024 brought 4 new FDA drug approvals in the oncology space. With new drug regimens in both the solid tumor and blood ...

The FDA expanded the approval of methotrexate to include patients with pediatric acute lymphoblastic leukemia and polyarticular juvenile idiopathic arthritis. The FDA approval of methotrexate (Jylamvo ...